European Journal of Haematology

Top Research Topics at European Journal of Haematology?

The foci of the journal are Internal medicine, Immunology, Gastroenterology, Pathology and Surgery. The concepts on Internal medicine presented in the journal can also apply to other research fields, including Endocrinology and Oncology. It focuses on Immunology but the discussions also offer insight into other areas such as Haematopoiesis and Cancer research.

European Journal of Haematology emphasizes research on Pathology, which includes concerns such as Lymphoma. Regimen is a focus of the Surgery works in it. The studies in Leukemia featured incorporate elements of Myeloid and Myeloid leukemia.

The majority of Multiple myeloma studies presented zero in on Bortezomib. The Transplantation study featured in it draws parallels with the field of Stem cell.

• Internal medicine (42.65%)
• Immunology (28.18%)
• Gastroenterology (17.21%)

What are the most cited papers published in the journal?

• Erythropoietin after a century of research: younger than ever. (309 citations)
• Renal failure in multiple myeloma: reversibility and impact on the prognosis (307 citations)
• Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo (278 citations)

Research areas of the most cited articles at European Journal of Haematology:

The most cited articles focus on Internal medicine, Immunology, Gastroenterology, Surgery and Pathology. The studies on Internal medicine discussed at the journal publications can also contribute to research in the domains of Endocrinology and Oncology. The featured Immunology studies in the journal publications mainly concentrate on Anemia but also cover areas of interest in Erythropoietin.

What topics the last edition of the journal is best known for?

• Internal medicine
• Cancer
• Gene

The previous edition focused in particular on these issues:

European Journal of Haematology mostly deals with topics like Internal medicine, Oncology, Gastroenterology, Multiple myeloma and Transplantation. Cohort, Myeloid leukemia, Disease, Chemotherapy and Incidence (epidemiology) studies are all carried out as a component of the study in Internal medicine presented. The study on Myeloid leukemia presented in European Journal of Haematology intersects with the topics under Leukemia.

While Oncology is the focus of it, it also provided insights into the studies of Ixazomib, Discontinuation, Myelodysplastic syndromes and Rituximab. Adverse effect, Refractory, Graft-versus-host disease and Lymphoma are some topics wherein Gastroenterology research discussed in European Journal of Haematology have an impact. Topics in Transplantation explored in it were investigated in conjunction with research in Stem cell, Cumulative incidence and Bone marrow.

The most cited articles from the last journal are:

• Association of anticoagulation dose and survival in hospitalized COVID-19 patients: A retrospective propensity score-weighted analysis. (19 citations)
• COVID-19 Vaccine-associated Immune Thrombosis and Thrombocytopenia (VITT): diagnostic and therapeutic recommendations for a new syndrome. (16 citations)
• SARS-CoV-2 infection among patients with haematological disorders: Severity and one-month outcome in 66 Danish patients in a nationwide cohort study. (10 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in European Journal of Haematology (based on the number of publications) are:

• Sante Tura (41 papers) absent at the last edition,
• Peter Hokland (38 papers) absent at the last edition,
• Magnus Björkholm (32 papers) published 3 papers at the last edition,
• Hans Carl Hasselbalch (28 papers) published 1 paper at the last edition the same number as at the previous edition,
• Ayalew Tefferi (28 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in European Journal of Haematology (based on the number of publications) are:

• Lund University (114 papers) published 4 papers at the last edition the same number as at the previous edition,
• Mayo Clinic (92 papers) published 6 papers at the last edition, 2 more than at the previous edition,
• Karolinska Institutet (92 papers) published 4 papers at the last edition, 2 less than at the previous edition,
• University of Copenhagen (87 papers) published 3 papers at the last edition, 1 more than at the previous edition,
• Boston Children's Hospital (87 papers) published 2 papers at the last edition, 1 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 8.38% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 22.29% were posted by at least one author from the top 10 institutions publishing in the journal. Another 9.14% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 18.29% of all publications and 50.29% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.